An agrivoltaics power plant on the plateau of Guizhou province, southwestern China, has been connected to the grid using ...

Over the past 15 years, Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products. CRISPR Therapeutics won its first regulatory ...

Zimislecel (formerly VX-880), Vertex’s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the Phase 1/2/3 study in patients ...

Singapore, Meylan (France) and Montreal (Canada) – April 15th, 2025 -- Vertex Growth is a growth-stage venture capital fund anchored by Vertex Holdings, a subsidiary of global investment firm Temasek.

After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma Kewalramani, M.D., to $21.5 million, according to the company’s proxy filing.

Vertex Solutions, a small business known for the manufacturing of systems integration and advanced training technologies, has been awarded a contract to deliver 25 additional T-38 Gen 2 enhanced ...

Google Cloud’s Vertex AI, a machine learning (ML) platform, is receiving significant updates. Vertex AI is a tool for enterprise AI development. Unlike consumer-facing AI like Gemini or ChatGPT ...

BOSTON, April 07, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2025 financial results on Monday, May 5, 2025 after the financial markets ...

In a series of recent legal challenges initiated by the pharmaceutical industry against the US Department of Health and Human Services Office of ...

OpenAI is embracing rival Anthropic’s standard for connecting AI assistants to the systems where data resides. In a post on X on Wednesday, OpenAI CEO Sam Altman said that OpenAI will add ...